Qatari research proves natural immunity theory for Covid-19 

New research from Qatar, published in the New England Journal of Medicine, has found that the natural immunity from prior infection of Covid-19 has a 92% efficacy against reinfection of the Beta variant, and a 98% efficacy against reinfection of the Alpha variant.  

The study 

The study looked at a national cohort of Qataris, comparing the reinfection rate of those who had previously been infected with Covid-19 before January 2021, to the infection rate of those who hadn’t.  


As Covid-19 cases continue to rise and the world responds to the Omicron variant, the findings come at a particularly important time. The Beta variant is the second most immune evasive variant behind Omicron, and the fact that the research found strong protection for Beta is encouraging. While Omicron has many more mutations, it is somewhat reassuring that there could be at least some partial protection for prior infection against reinfection with Omicron. 

Image credit: Rowen Smith

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free